Thermo Fisher Scientific, the world leader in serving science, today announced the launch of the Applied Biosystems TaqPath Respiratory Viral Select Panel; a CE-IVD-marked molecular assay panel for detection of five common viruses, including those that cause the common cold, bronchiolitis, croup, influenza-like illnesses, and pneumonia.
The molecular assay panel provides results in approximately three hours, testing for Adenovirus, Human Metapneumovirus, Rhinovirus/Enterovirus, and Parainfluenza virus, using highly accurate PCR technology. RNase P and positive controls are included to offer sample-to-result reliability.
The solution is scalable, which allows laboratories to run from one to 94 samples simultaneously depending on the needs of the population they’re servicing and can help to identify co-infections. “Offering information on these other common respiratory viruses in a single test empowers labs to detect them quickly and efficiently so that the right treatment approach can be selected, which can help save patient’s lives”, said Dr. Manoj Gandhi, senior medical director of Genetic Testing Solutions at Thermo Fisher Scientific.
Read more about this news here.
